Increased risk of venous thrombosis by AB alleles of the ABO blood group and Factor V Leiden in a Brazilian population

Genetics and Molecular Biology

Volumn 32, Issue 2, 2009, Pages 264-267

  Lima, Magaly B P L V ^a   de Oliveira Filho, Aldemir Branco ^a   Campos, Júlia F ^b   Melo, Fárida C B C ^b   Batista das Neves, Washington ^b   Melo, Raul Antônio Morais ^b   Lemos, José Alexandre Rodrigues ^a,c  

^a Laboratorio de Testes de Acidos Nucleicos   (Brazil)

^b Fundacao de Hematologia e Hemoterapia de Pernambuco   (Brazil)

^c FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

ABO blood group; Factor V Leiden; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; GENOMIC DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD GROUP ABO SYSTEM; BRAZIL; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; VEIN THROMBOSIS;

EID: 66649132499     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572009000200010     Document Type: Article

References (22)

1. Ayres M, Ayres Jr M, Ayres DM and Santos AS (2005) BioEstat 4.0 Aplicações Estatísticas nas Áreas das Ciências Biológicas e Médicas. Sociedade Civil Mamirauá, Belém, 324 pp.
2. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA and Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-70.
3. Biron-Adreani C, Morangi P-E, Le Havre R, Le Cam-Duchez V, Borg J-E, Saladin-Thiron C, Bauters A, Jude B, Aillaud M-F, Juhan-Vague I et al. (2006) ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: A study of 180 homozygotes for the Factor V Leiden mutation. Br J Haematol 135:697-702.
4. Cripe LD, Moore KD and Kane WH (1992) Structure of the gene for human coagulation factor V. Biochemistry 31:3777-3785.
5. Dahlbäck B (2003) The discovery of activated protein C resistance. J Thromb Haemost 1:3-9.
6. Dahlbäck B and Villoutrex BO (2003) Molecular recognition in the protein C anticoagulant pathway. J Throm Haemost 1:1524-1534.
7. Franco RF and Reitsma PH (2001) Genetic risk factors venous thrombosis. Hum Genet 109:369-384.
8. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ and Montgomery RR (1987) The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69:1691-1695.
9. Jick H, Westerholm B, Vessey MP, Lewis GP, Stone D, Inman WHW, Shapiro S and Worcester J (1969) Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet 1:539-542.
10. Kamphuisen PW, Howing-Duistermaat JJ, Van Houwelingen HC, Eikenboom JCJ, Bertina RM and Rosendaal FR (1998) Familial clustering of factor VIII and von Willebrand factor levels. J Thromb Haemost 79:323-327.
11. Koster T, Blann AD, Vandenbrouck JP and Rosendaal FR (1995) Role of clotting factorVIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152-155.
12. Matsui T, Titani K and Mizuoch T (1992) Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor: Ocurrence of blood group A, B and H structures. J Biol Chem 267:8723-8731.
13. Morelli VM, De Visser MCH, Vos HL, Bertina RM and Rosendaal FR (2005) ABO blood group genotypes and the risk of venous thrombosis: Effect of factor V Leiden. J Thromb Haemost 3:183-185.
14. Ohira T, Cushman M, Tsai MY, Zhang Y, Heckbert SR, Zakai NA, Rosamond WD and Folsom AR (2007) ABO blood group, other risk factors and incidence of venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost 5:1455-1461.
15. Orstavick KH, Magnus P, Reisner H, Berg K, Grahan JB and NanceW(1985) Factor VIII and Factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 37:89-101.
16. Preston AE and Barr A (1964) The plasma concentration of factor VIII in the normal population. Br J Haematol 10:238-245.
17. Robert A, Aillaud MF, Eschwege V, Randrianjohany A, Scarabi Y and Juhan-Vague I (2000) ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden. J Thromb Haemost 83:630-631.
18. Sodetz JM, Paulson JC and McKe PA (1979) Carbohydrate composition and identification of blood groups A, B and H oligosaccharide structures on human Factor VIII/von Willebrand factor. J Biol Chem 254:10.754-10.760.
19. Svensson PJ and Dahlbäck B (1994) Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517-522.
20. Tirado I, Mateo J, Soria JM, Oliver A, Martinez-Sànchez E, Vallvé C, Borrell M, Urrutia T and Fontcuberta J (2005) The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost 93:468-474.
21. Váradi K, Rosing J,Tans G, Pabinger I, Keil B and Schwarz HP (1996) Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: Influence of the factor V R506Q mutation. J Thromb Haemost 76:204-208.
22. Wang H, Riddell DC, Guinto ER, McGillvray RTA and Hamerton JL (1988) Localization of the encoding human factor V to chromosome 1q21-25. Genomics 2:324-328.